BioCentury | Apr 14, 2021
Management Tracks

Management shuffle at Novavax; plus Skyhawk, Kyverna, Gemini and more

...Smith to SVP of discovery and preclinical research and chief scientist. Morgan joins from EMD Serono...
BioCentury | Feb 5, 2021
Management Tracks

Chugai names Okuda CEO; plus Astellas promotes Barretto-Ko to CBO, Goto to CSO and updates from Merck KGaA, Scholar Rock, Berkeley Lights, Catamaran and more

...Spark Therapeutics Inc., which Roche acquired in 2019. Rehan Verjee stepped down as president of EMD Serono...
BioCentury | Oct 13, 2020
Finance

Chord launches with $16M to test MS drug cladribine in rare autoimmune disorders

...hairy cell leukemia, the therapy was then developed as an oral tablet by the EMD Serono...
BioCentury | Oct 2, 2020
Product Development

With patient groups’ endorsement, Amylyx, FDA to discuss approval of ALS therapy

...if and when the moment comes.In August, Amylyx hired former Biogen Inc. (NASDAQ:BIIB) and EMD Serono...
BioCentury | Apr 24, 2020
Emerging Company Profile

FoRx: A broader look at DNA damage repair

...Goutopoulos is an entrepreneur in residence at M Ventures, senior scientific director at the EMD Serono...
BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...North America. Ziezula was president and managing director of the Merck KGaA (Xetra:MRK) subsidiary EMD Serono...
BioCentury | Mar 17, 2020
Product Development

March 16 Quick Takes: FDA raises efficacy questions for DBV allergy therapy; plus Novo, Provention, UCB, Pfizer-EMD Serono, Zai, AcelRx-Tetraphase, Medivir-Tan

...indication. EMD Serono, Pfizer stop Phase III Bavencio study Pfizer Inc. (NYSE:PFE) and the EMD Serono...
BioCentury | Jan 24, 2020
Product Development

The new drug development -- collaborative and people-powered

...to those living each day with a chronic condition. Accelerated Cure Project (ACP) and EMD Serono...
...and delivery. Specifically, this partnership is using ACP’s research network, iConquerMS , to inform EMD Serono’s...
...of the ACP-iConquerMS - EMD Serono collaboration. Fundamentally, this collaboration represents a growth in EMD Serono’s...
BioCentury | Jan 7, 2020
Company News

Jan. 6 Company Quick Takes: China approvals for AZ, Sanofi and Gene+; plus Apollomics-GlycoMimetics, Pfizer-Merck KGaA and more

...extends OS in Phase III for 1L bladder cancer Pfizer Inc. (NYSE:PFE) and the EMD Serono...
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...She was the franchise lead, immunology and neurology, global drug safety innovation at the EMD Serono...
Items per page:
1 - 10 of 1516
BioCentury | Apr 14, 2021
Management Tracks

Management shuffle at Novavax; plus Skyhawk, Kyverna, Gemini and more

...Smith to SVP of discovery and preclinical research and chief scientist. Morgan joins from EMD Serono...
BioCentury | Feb 5, 2021
Management Tracks

Chugai names Okuda CEO; plus Astellas promotes Barretto-Ko to CBO, Goto to CSO and updates from Merck KGaA, Scholar Rock, Berkeley Lights, Catamaran and more

...Spark Therapeutics Inc., which Roche acquired in 2019. Rehan Verjee stepped down as president of EMD Serono...
BioCentury | Oct 13, 2020
Finance

Chord launches with $16M to test MS drug cladribine in rare autoimmune disorders

...hairy cell leukemia, the therapy was then developed as an oral tablet by the EMD Serono...
BioCentury | Oct 2, 2020
Product Development

With patient groups’ endorsement, Amylyx, FDA to discuss approval of ALS therapy

...if and when the moment comes.In August, Amylyx hired former Biogen Inc. (NASDAQ:BIIB) and EMD Serono...
BioCentury | Apr 24, 2020
Emerging Company Profile

FoRx: A broader look at DNA damage repair

...Goutopoulos is an entrepreneur in residence at M Ventures, senior scientific director at the EMD Serono...
BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...North America. Ziezula was president and managing director of the Merck KGaA (Xetra:MRK) subsidiary EMD Serono...
BioCentury | Mar 17, 2020
Product Development

March 16 Quick Takes: FDA raises efficacy questions for DBV allergy therapy; plus Novo, Provention, UCB, Pfizer-EMD Serono, Zai, AcelRx-Tetraphase, Medivir-Tan

...indication. EMD Serono, Pfizer stop Phase III Bavencio study Pfizer Inc. (NYSE:PFE) and the EMD Serono...
BioCentury | Jan 24, 2020
Product Development

The new drug development -- collaborative and people-powered

...to those living each day with a chronic condition. Accelerated Cure Project (ACP) and EMD Serono...
...and delivery. Specifically, this partnership is using ACP’s research network, iConquerMS , to inform EMD Serono’s...
...of the ACP-iConquerMS - EMD Serono collaboration. Fundamentally, this collaboration represents a growth in EMD Serono’s...
BioCentury | Jan 7, 2020
Company News

Jan. 6 Company Quick Takes: China approvals for AZ, Sanofi and Gene+; plus Apollomics-GlycoMimetics, Pfizer-Merck KGaA and more

...extends OS in Phase III for 1L bladder cancer Pfizer Inc. (NYSE:PFE) and the EMD Serono...
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...She was the franchise lead, immunology and neurology, global drug safety innovation at the EMD Serono...
Items per page:
1 - 10 of 1516